Silverback Therapeutics Statistics Share Statistics Silverback Therapeutics has 93.77M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 93.77M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 11.64M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 846.1K, so 0% of the outstanding
shares have been sold short.
Short Interest 846.1K Short % of Shares Out n/a Short % of Float 3.48% Short Ratio (days to cover) 3.06
Valuation Ratios The PE ratio is 71.15 and the forward
PE ratio is null.
Silverback Therapeutics's PEG ratio is
-0.62.
PE Ratio 71.15 Forward PE n/a PS Ratio 6.38 Forward PS n/a PB Ratio 2.22 P/FCF Ratio 43.82 PEG Ratio -0.62
Financial Ratio History Enterprise Valuation Silverback Therapeutics has an Enterprise Value (EV) of 518.24M.
EV / Sales 5.81 EV / EBITDA -168.1 EV / EBIT 38.25 EV / FCF 39.91
Financial Position The company has a current ratio of 14.26,
with a Debt / Equity ratio of 0.
Current Ratio 14.26 Quick Ratio 14.04 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 3.11% and Return on Invested Capital is -0.91%.
Return on Equity 3.11% Return on Assets 2.28% Return on Invested Capital -0.91% Revenue Per Employee $990.54K Profits Per Employee $88.87K Employee Count 90 Asset Turnover 0.25 Inventory Turnover 0.19
Taxes Income Tax 288K Effective Tax Rate 3.48%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Silverback Therapeutics's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 5.39 200-Day Moving Average 4.38 Relative Strength Index (RSI) 53.52 Average Volume (20 Days) 171,415
Income Statement In the last 12 months, Silverback Therapeutics had revenue of 89.15M
and earned 8M
in profits. Earnings per share was 0.08.
Revenue 89.15M Gross Profit 88.17M Operating Income -3.08M Net Income 8M EBITDA -3.08M EBIT -3.08M Earnings Per Share (EPS) 0.08
Full Income Statement Balance Sheet The company has 50.82M in cash and 42K in
debt, giving a net cash position of 50.77M.
Cash & Cash Equivalents 50.82M Total Debt 42K Net Cash 50.77M Retained Earnings -123.31M Total Assets 327.32M Working Capital 276.24M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 13.55M
and capital expenditures -563K, giving a free cash flow of 12.98M.
Operating Cash Flow 13.55M Capital Expenditures -563K Free Cash Flow 12.98M FCF Per Share 0.13
Full Cash Flow Statement Margins Gross margin is 98.9%, with operating and profit margins of -3.46% and 8.97%.
Gross Margin 98.9% Operating Margin -3.46% Pretax Margin 9.29% Profit Margin 8.97% EBITDA Margin -3.46% EBIT Margin -3.46% FCF Margin 14.57%
